Efficacy News and Research

RSS
Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Esperion Therapeutics reports positive results from ETC-1002 Phase 2a study for LDL-C treatment

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Apitope successfully completes ATX-MS-1467 Phase I trial in relapsing MS patients with positive results

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Imaxio's pro-immunogenic technology used in tuberculosis vaccine phase I clinical study

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

Renin inhibitor aliskiren not effective in slowing progression of coronary atherosclerosis

Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study

Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study

Acacia Pharma raises $23.5 million in Series B financing

Acacia Pharma raises $23.5 million in Series B financing

Facebook groups are effective tool for increasing HIV testing among at-risk populations

Facebook groups are effective tool for increasing HIV testing among at-risk populations

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

Argininosuccinic aciduria (ASA) and gene therapy: an interview with Dr Julien Baruteau, UCL Institute for Women's Health, London

Women are 25% less likely to die post TAVI than men, says doctor

Women are 25% less likely to die post TAVI than men, says doctor

Roche's Herceptin formulation wins EU approval for treatment of HER2-positive breast cancer

Roche's Herceptin formulation wins EU approval for treatment of HER2-positive breast cancer

Use of anticoagulant does not reduce ischemic events among patients undergoing PCI

Use of anticoagulant does not reduce ischemic events among patients undergoing PCI

CAD patients with very low LDL-C levels benefit from statin treatment

CAD patients with very low LDL-C levels benefit from statin treatment

New delivery system for combination of 2 FDA approved drugs to fight HIV

New delivery system for combination of 2 FDA approved drugs to fight HIV

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

Study describes lack of positive effects in drugs, long-term data and robust direct comparisons in RA

Researchers find new form of imaging technology to diagnose different types of cancer

Researchers find new form of imaging technology to diagnose different types of cancer

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

Mallinckrodt to present MNK-795 clinical data at PAINWeek 2013

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Reformulated OxyContin®: an interview with Dr. Paul Coplan, Executive Director, Risk Management and Epidemiology, Purdue Pharma

Testosterone improves exercise capacity in men with COPD

Testosterone improves exercise capacity in men with COPD

Inflammatory status upregulated in first-episode schizophrenia

Inflammatory status upregulated in first-episode schizophrenia

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

Alzheimer’s drug trial: an interview with Geoffrey Kempler, Chairman & CEO Prana Biotechnology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.